about
Non-Covalent Derivatives: Cocrystals and EutecticsPharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and DevelopmentSmall-Scale Assays for Studying Dissolution of Pharmaceutical Cocrystals for Oral Administration.Acemetacin cocrystal structures by powder X-ray diffraction.Immunotoxicological Effects of Aripiprazole: In vivo and In vitro Studies.Impact of Micellar Surfactant on Supersaturation and Insight into Solubilization Mechanisms in Supersaturated Solutions of Atazanavir.Mechanistic Analysis of Cocrystal Dissolution as a Function of pH and Micellar SolubilizationCocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.Cocrystal Transition Points: Role of Cocrystal Solubility, Drug Solubility, and Solubilizing Agents.Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics.New forms of old drugs: improving without changing.Multicomponent Crystal Systems of Known Antimalarial Drug Molecules.Insoluble drug delivery strategies: review of recent advances and business prospects.Nanoformulation and encapsulation approaches for poorly water-soluble drug nanoparticles.Application of UV Imaging in Formulation Development.Engineering and manufacturing of pharmaceutical co-crystals: a review of solvent-free manufacturing technologies.Towards medicinal mechanochemistry: evolution of milling from pharmaceutical solid form screening to the synthesis of active pharmaceutical ingredients (APIs).Stabilisation of an amorphous form of ROY through a predicted co-former interaction.In silico screening of dicarboxylic acids for cocrystallization with phenylpiperazine derivatives based on both cocrystallization propensity and solubility advantage.Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carbamazepine-Succinic Acid Cocrystal in Matrix Tablets.A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.Eutectics as improved pharmaceutical materials: design, properties and characterization.Synergistic Effect of Polyvinyl Alcohol and Copovidone in Itraconazole Amorphous Solid Dispersions.Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.Comparison of the relative stability of pharmaceutical cocrystals consisting of paracetamol and dicarboxylic acids.Introductory lecture: Mechanochemistry, a versatile synthesis strategy for new materials.From a binary salt to salt co-crystals of antibacterial agent lomefloxacin with improved solubility and bioavailability.Evaluating the Energetic Driving Force for Cocrystal Formation.Preparation and characterization of adefovir dipivoxil-stearic acid cocrystal with enhanced physicochemical properties.Directed self-assembled nanoparticles of probucol improve oral delivery: fabrication, performance and correlation.Survival of the Fittest: Competitive Co-crystal Reactions in the Ball Mill.Multicomponent solid forms of felodipine: preparation, characterisation, physicochemical and in-vivo studies.Controlled production of the elusive metastable form II of acetaminophen (paracetamol): a fully scalable templating approach in a cooling environment.Structural studies of crystalline forms of triamterene with carboxylic acid, GRAS and API molecules.Investigation of the effect of hydroxypropyl methylcellulose on the phase transformation and release profiles of carbamazepine-nicotinamide cocrystalEngineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous MediumPharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble DrugsRecent advances in improving oral drug bioavailability by cocrystalsPreparation and characterization of spray-dried co-amorphous drug-amino acid salts
P2860
Q26796674-C6980B82-482F-4978-92D7-0499903EDB61Q28468556-56254A62-9D6D-4987-97E5-160C85CA9AA7Q30375810-AD416A26-7F09-4D3B-8FE4-70E8D83C921DQ33630701-9AD7C633-CCF7-42AD-9792-1AA8A5D0227CQ35843979-00DFAD3D-E840-4E94-8375-4AD73684B214Q36326329-9AEEDCDB-FD7B-4C56-A56C-6B341FC19410Q36666790-45ACA71C-6524-434F-BFFC-66D99A7ABA3AQ37013110-76B8A91B-B58C-4D1F-9B2A-EAA9B364A3F3Q37155004-D26B0858-2C7E-4B55-AF1A-CF4AB8B9BC2EQ37415146-9DFB2CC4-6B6E-4A51-9C5A-32E7D4326AC5Q38236638-33E17FE5-6F48-4943-B53D-2830E4DD3EFEQ38342804-E9BF08C6-B03E-42E8-865E-647ADBC50ADCQ38586521-4B30DFE2-6D7E-41DC-ABB3-E9F51E5540D6Q38637003-1C050940-139D-4841-841A-6BDE77992AC6Q38687039-905AE60C-D1D9-40E8-AE5D-772237421242Q38808298-3C43142E-F356-4976-A54D-A382164D613DQ38865422-27F2FADE-46C2-49D0-A5BB-2F8D15DD9863Q38866596-41E7436E-1532-4364-B086-C896784556ACQ38876711-4B840246-3736-46C8-9C74-5AAE1D83C09DQ41888978-8075E184-6D5E-46E3-813E-A5321497D783Q42581894-7AEC01B5-510A-4EEC-8F3A-BEAD78876D4DQ43776696-1503013E-A2A3-4D78-9E1D-3635316C0229Q44122680-5BD1BF54-75A6-467C-9169-D05E15E3101EQ47729955-925A7F1C-E39D-4F8F-9E79-A1D6165FFFB6Q48166645-C14C6BBA-CA89-4F8A-8B11-8C8CE93929CBQ48314127-6466A83C-56CE-48E2-AB33-4F041B453C38Q48520512-426B32CA-EB63-41D6-A3BF-3E5A53E44CADQ50253279-A6186206-AC67-4EBF-808F-27D40D72745EQ50281310-ADAA7FBA-5F1A-48F4-9B5A-66B9D64DB437Q50865947-11E12C21-BB7E-45C0-8327-77E6ACB6D965Q51750624-715948A1-4068-46B5-B7BF-6D1AB0865A2CQ51786790-CE256301-2AE9-4A4B-AD65-B4E7E12B2C71Q53540013-934332A4-A1DF-4E9A-9474-EB3D322B10A4Q53770646-0B903E3B-7B9A-46E4-997B-3547270A8099Q55394847-94DFD857-2FB4-4CE9-9382-46E697FC5F0DQ57162923-6262C671-721D-4F2B-8361-1F94931E95A7Q57174036-B662F09E-BC2A-4A59-BE43-E96951D9DA49Q58032213-DD3A07E0-E7EB-4B84-BDDD-CB1C76C8B2DCQ58578289-12D32F89-9AAA-4912-A46A-E0A3601A4934Q59234161-1EDFA2E3-94A7-40C4-BFBE-2171DB0D0858
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmaceutical cocrystals and poorly soluble drugs.
@en
type
label
Pharmaceutical cocrystals and poorly soluble drugs.
@en
prefLabel
Pharmaceutical cocrystals and poorly soluble drugs.
@en
P2093
P1476
Pharmaceutical cocrystals and poorly soluble drugs
@en
P2093
Amit Delori
Maya P Lipert
Naír Rodríguez-Hornedo
William Jones
P304
P356
10.1016/J.IJPHARM.2012.10.043
P407
P577
2012-12-01T00:00:00Z